Court
Cases
T-472/13,T-460/13,T-467/13,T-
|
||
8/9/2016 - The Commission welcomes the General Court's
jugments which upheld the Commission's Lundbeck decision (cases T-472/13,
T-460/13, T-467/13, T-469/13, T-470/13, T-471/13) and ruled for the first
time that pharma pay-for-delay agreements breach EU antitrust rules. In
such agreements an original pharmaceutical manufacturer pays generics
producers to stay out of the market.
The Commission's decision found that
the Danish pharmaceutical company Lundbeck and four generics competitors
had concluded agreements that harmed patients and health care systems.
This allowed Lundbeck to keep the price of its blockbuster drug
citalopram artificially high, in breach of Article 101 of the Treaty on
the Functioning of the European Union.
The decision imposed a fine of
€93.8 million on Lundbeck and fines totalling €52.2 million on the four
generics competitors, Generics UK, Arrow, Alpharma and Ranbaxy. Fact sheet/Memo |
||
|
Case T-54/14
Goldfish (Heiploeg) vs. European Commission (Shrimps case)
8/9/2016 - The Commission welcomes the judgment by the
General Court, which upholds the Commission's assessment of the North Sea
Shrimps cartel for Goldfish and other entities of the Heiploeg group.
In
November 2013, the Commission fined Goldfish and other entities of the
Heiploeg group €27 million for operating a long-term cartel in breach of
EU antitrust rules (see IP/13/1175).
The Commission found that Heiploeg
and other North Sea shrimps traders bilaterally discussed a wide range of
aspects of their business, including their purchase prices from
fishermen, conduct towards other traders on the market, market sharing,
and prices charged to specific important customers that often set the
benchmark price for other customers.
|
Case C‑101/15 P
Pilkington Group vs. European Commission (Appeal)
|
8/9/2016 - The court of justice ruled on an appeal against
a ruling in the carglass-cartel.
The appellant argued against the initial findings of the court regarding an earlier appeal. The court dismissed the appeal in full. |
Post
Nessun commento:
Posta un commento